Men with BMI, which is a predominant profile in T2DM and individuals with metabolic syndrome, likely exhibit hemodilution from increased plasma volume and lower androgen levels, which might facilitate a decrease in prostate size and lower the PSA [27,28]. This evidence concerns the gene KLK3 and metabolic syndrome.